News of the day
Novasep Gains SafeBridge(R) "Potent Compound Safety Certification" for its Le Mans Facility
17th September 2009
POMPEY, France, September 17 /PRNewswire/ -- Novasep is pleased to announce that its site in Le Mans -
France, specialized in the development and manufacturing of Highly Potent
Active Pharmaceutical Ingredients (HPAIs), has received the "Potent Compound
Safety Certification" from SafeBridge(R) Consultants, Inc.
The SafeBridge(R) Potent Compound Safety Certification program
verifies Novasep's performance in the management, evaluation, containment,
control and communication elements of HPAI...
more
WEHI Spin-Out MuriGen Restructures G-CSF Antagonist Program With CSL
27th October 2008
MELBOURNE, Australia, October 27 /PRNewswire/ -- MuriGen Therapeutics today announced that its collaboration with CSL for
the development of a new class of drugs that target arthritis and other
inflammatory diseases has been restructured.
The collaboration was initially established in February 2006 by MuriGen
Therapeutics and Zenyth Therapeutics Limited (now part of CSL Limited) and is
developing therapeutic antibodies that inhibit the activity of the cytokine
granulocyte colony...
more
Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
8th October 2008
SAN DIEGO, October 8 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing
innovative therapeutics for the treatment of viral infections and cancer,
today provided an update on its ongoing development programs. The company
also announced that it will initiate a corporate restructuring that will
extend the company's financial resources to pursue near-term corporate
development opportunities, sale of specific programs, M&A and alternative
financial...
more
PR Newswire search
Browse by category
More recent news
Merck Serono and ZymoGenetics Restructure Partnership
3rd September 2008 GENEVA, Switzerland, September 3 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and
ZymoGenetics, Inc. (NASDAQ: ZGEN), Seattle, United States, today announced...
All rights reserved. Terms and Conditions | Contact us
